Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Rundo Pharmaceutical R&D

Request full access

Shanghai full-service clinical CRO and SMO platform

Huangpu, ChinaFounded 2004Biotech & Life Sciences

About Rundo Pharmaceutical R&D

Rundo Pharmaceutical R&D (Shanghai) Co., Ltd. (润东医药) is a Shanghai-based clinical contract research organization founded in 2004. It provides Phase I–IV clinical trial management under ICH-GCP and NMPA rules across oncology, cardiovascular, respiratory, GI, endocrine and neurology, plus SMO (Premium SMO), Phase I unit management and biostatistics subsidiaries, with stated coverage across dozens of Chinese cities and international reach into APAC, Europe and the US. Public materials cite 1,500+ completed clinical projects and early ISO 9001 / China CRO industry-standard certification.

Source: Dealroom company data

At a glance

Status
Operational
Employees
44
Open positions
1
Dealroom signal
22.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC May 2019 $15M $60M River Head Capital —
SERIES BEquity / VC Jun 2017 $0 — Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Rundo Pharmaceutical R&D website traffic

Latest recorded traffic for Rundo Pharmaceutical R&D is 70 monthly website visits, down 61.1% over the last three months. Rundo Pharmaceutical R&D's team grew 0% over the past year.

Latest monthly visits70 3-month web change-61.1% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Rundo Pharmaceutical R&D in the Huangpu ecosystem

Live from Dealroom

The Rundo Pharmaceutical R&D office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • River Head Capital
Employees 44 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Rundo Pharmaceutical R&D on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Rundo Pharmaceutical R&D’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.